December 28, 2016
(UPI) – Scientists have developed a technology to control mesenchymal stem cells or MSCs, in an effort to fight cancer cells in the body. Researchers from Tomsk Polytechnic University’s Laboratory of Novel Dosage are using a patient’s own magnetic stem cells to target cancer cells effectively. The team collaborated with scientists from Pavlov State Medical University of St. Petersburg and Queen Mary University in London, England.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.